SST Funding: How Much Did They Raise & Key Investors

How Much Did SST Raise?
Funding & Key Investors

SST Corporation, a long-standing supplier of active pharmaceutical ingredients (APIs), has secured $350K in total capital, with its most recent financing round amounting to $350K. This major strategic investment underscores the company's established position in the pharmaceutical supply chain and its ongoing efforts to meet the dynamic needs of the global market.

What is SST?

SST

Retail

Drug Stores & Pharmacies

Founded in 1948, SST Corporation is a prominent provider of active pharmaceutical ingredients (APIs), serving a broad spectrum of clients from major generic pharmaceutical companies to emerging startups. The company prides itself on robust global supplier partnerships, ensuring the delivery of high-quality products. SST's operational excellence is further bolstered by a commitment to stringent regulatory compliance, advanced supply chain management, and dedicated customer service, all managed by a team of seasoned industry professionals.

How much funding has SST raised?

SST has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

What's next for SST?

With its recent strategic investment and substantial total funding, SST is well-positioned for continued growth and expansion within the competitive API market. The company's focus on maintaining its expansive global supplier network and adhering to high standards of quality and regulatory affairs suggests a strategy geared towards solidifying its market leadership and potentially exploring new avenues for product development or service enhancement. This capital infusion is expected to support SST's ongoing mission to be a reliable and high-quality partner in the pharmaceutical industry.

See full SST company page

See More Financial Insights